Overview

Dissemination of a Tailored Tobacco Quitline for Rural Veteran Smokers

Status:
Unknown status
Trial end date:
2018-01-01
Target enrollment:
Participant gender:
Summary
The project is designed to examine the effectiveness of strategies to increase access to treatment for tobacco use and dependence among rural Veteran smokers. In addition, it will examine whether tailored treatment that is designed to address common comorbid conditions that are related to cigarette smoking enhances success with quitting relative to enhanced standard of care. The investigators hypothesize that participants assigned to the tailored tobacco cessation intervention will report greater cessation rates at six months. The investigators also anticipate more favorable outcomes on measures of depressive symptoms, alcohol use, and body weight.
Phase:
Phase 3
Details
Lead Sponsor:
Mark Vander Weg
University of Iowa
Collaborator:
VA Office of Research and Development
Treatments:
Bupropion
Ethanol
Nicotine
Varenicline